Results 71 to 80 of about 14,835 (171)

Carvedilol and bisoprolol effectiveness in patients with myocardial infarction and heart failure

Кардиоваскулярная терапия и профилактика, 2008
Aim. To assess carvedilol and bisoprolol effects on clinical symptoms, hemodynamics and morpho-functional heart characteristics in patients with myocardial infarction (MI) and chronic heart failure (CHF).Material and methods.
A. I. Chesnikova, E. A. Lavrik, I. V. Bedareva, I. N. Koshenskaya   +3 more
doaj  

Is carvedilol superior to propranolol in patients with cirrhosis with portal hypertension: a systematic and meta-analysis

Drugs in Context
Background: Carvedilol has shown greater potency than propranolol as a β-blocker in managing cardiac conditions. However, its efficacy in reducing portal hypertension (PHTN) in patients with cirrhosis remains unclear.
Siddheesh Rajpurohit, Balaji Musunuri, Pooja Basthi Mohan, Ganesh Bhat, Shiran Shetty   +4 more
doaj   +1 more source

Carvedilol sensitizes chemotherapy by targeting STING to boost anti-tumor immunity

Cell Reports
Summary: The stimulator of interferon genes (STING)-mediated type I interferon (IFN) response is critical for mounting anti-tumor immunity and sensitizing chemotherapy by remodeling the tumor immune microenvironment.
Yifang Dang, Mingtong Ma, Yan Wang, Mengmeng Zhao, Yajuan Cao, Hang Su, Tianhao Liu, Mengge Zheng, Jiani Gao, Xiangyang Wu, Junfang Xu, Li Chen, Jianzhong Jeff Xi, Yiyan Fei, Haipeng Liu   +14 more
doaj   +1 more source

Carvedilol

New England Journal of Medicine, 1998
openaire   +4 more sources

Carvedilol in the treatment of chronic heart failure: Lessons from The Carvedilol Or Metoprolol European Trial

Vascular Health and Risk Management, 2007
Britt Kveiborg, Atheline Major-Petersen, Buris Christiansen, Christian Torp-PedersenDepartment of Cardiology, Bispebjerg University Hospital, Copenhagen, DenmarkAbstract: Beta-blockers have been shown to improve survival in patients with chronic heart ...
Britt Kveiborg, Atheline Major-Petersen, Buris Christiansen, Christian Torp-Pedersen   +3 more
doaj  

Model-informed dose optimization of carvedilol and nebivolol in cirrhotic patients: a pilot randomized clinical study. [PDF]

Sci Rep
Tarek M, Ali AA, Biomy R, Abdelkawy K, El-Khateeb E.   +4 more
europepmc   +1 more source

Beta Blocker Toxicity at Therapeutic Doses: A Look Into Carvedilol Use in the Elderly. [PDF]

Clin Case Rep
Amo-Tachie S.
europepmc   +1 more source

Sugar-Based Eutectic Systems Combined with Cyclodextrins for Enhanced Solubility of Carvedilol. [PDF]

Molecules
Polo A, Werner Á, Zuriaga E, Giner B, Lomba L.   +4 more
europepmc   +1 more source

Carvedilol [PDF]

Reactions Weekly, 2021
openaire   +2 more sources

Prognostic Impact of Carvedilol vs. Metoprolol on Long-Term Outcomes in Patients with Heart Failure and Mildly Reduced Ejection Fraction. [PDF]

J Clin Med
Weidner K, Behnes M, Reinhardt M, Abel N, Schmitt A, Lau F, Abumayyaleh M, Hetjens S, Steffen HJ, Akin I, Schupp T.   +10 more
europepmc   +1 more source